Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
Nicole Leite Galvão-CoelhoWolfgang MarxMaria GonzalezJustin SinclairMichael de ManincorDaniel PerkinsJerome SarrisPublished in: Psychopharmacology (2021)
Despite the concerns over unblinding and expectancy, the strength of the effect sizes, fast onset, and enduring therapeutic effects of these psychotherapeutic agents encourage further double-blind, placebo-controlled clinical trials assessing them for management of negative mood and depressive symptoms.
Keyphrases
- depressive symptoms
- sleep quality
- clinical trial
- placebo controlled
- double blind
- bipolar disorder
- end stage renal disease
- social support
- phase ii
- ejection fraction
- newly diagnosed
- chronic kidney disease
- phase iii
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- radiation therapy
- physical activity
- phase ii study